# OnCo record amsacrine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/amsacrine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "amsacrine" ;
  schema:name "Amsacrine"@en ;
  schema:alternateName "m-AMSA"@en, "Amsidine / Amsidyl" ;
  schema:description "Amsacrine is an intravenous leukaemia drug, approved in Europe, Canada and Australia in the 1980s, used mainly for acute myeloid leukaemia that has relapsed or resisted anthracycline-based treatment."@en ;
  schema:url <https://onco.cc/drugs/amsacrine/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Amsacrine> ;
  schema:citation <https://en.wikipedia.org/wiki/Amsacrine>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1200856> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Acridine topoisomerase II inhibitor, intravenous" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/top2a/> ;
  onco:drugs <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/etoposide/> ;
  onco:trials <https://onco.cc/trials/nct00002658/>, <https://onco.cc/trials/nct00003436/>, <https://onco.cc/trials/nct00002719/> .